Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
zolpidem tartrate
|
| gptkbp:approvedBy |
1992
|
| gptkbp:ATCCode |
N05CF02
|
| gptkbp:availableOn |
gptkb:Australia
gptkb:France various countries |
| gptkbp:brand |
gptkb:Ambien
gptkb:Edluar gptkb:Zolpimist gptkb:Intermezzo gptkb:zolpidem |
| gptkbp:contraindication |
sleep apnea
severe liver impairment |
| gptkbp:drugClass |
nonbenzodiazepine hypnotic
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:halfLife |
about 2.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Stilnox
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Sanofi
|
| gptkbp:onset |
gptkb:fire
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
C (US) |
| gptkbp:riskFactor |
dependence
withdrawal symptoms |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
headache drowsiness hallucinations |
| gptkbp:usedFor |
treatment of insomnia
|
| gptkbp:bfsParent |
gptkb:zolpidem
|
| gptkbp:bfsLayer |
6
|